CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Young Youn Cho, Young Hwan Choi, Su Jong Yu, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
J Liver Cancer. 2019;19(2):128-135.   Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.128

Excel Download

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
Journal of Liver Cancer. 2019;19(2):128-135   Crossref logo
Link1 Link2 Link3

Exam 2: Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Clinical Gastroenterology and Hepatology. 2012;10(8):e68   Crossref logo
Link1 Link2

Mo1501 Similar Transplant-Free Survival With Transarterial Chemoembolization (TACE) Versus Transarterial Radioembolization (TARE) in Patients With Hepatocellular Carcinoma
Gastroenterology. 2016;150(4):S1132-S1133   Crossref logo
Link1 Link2

Transarterial chemoembolization and renal failure in hepatocellular carcinoma patients: authors' reply
Liver International. 2009;30(6):924-925   Crossref logo
Link1 Link2

Nonresectable Hepatocellular Carcinoma: Long-term Toxicity in Patients Treated with Transarterial Chemoembolization—Single-Center Experience
Yearbook of Diagnostic Radiology. 2009;2009:212-214   Crossref logo
Link1 Link2

Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Clinical Gastroenterology and Hepatology. 2012;10(8):941-946   Crossref logo
Link1 Link2

Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization
Hepatology. 2008;47(6):2144-2144   Crossref logo
Link1 Link2

A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients
Cancer Management and Research. 2021;Volume 13:5373-5382   Crossref logo
Link1 Link2

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study
Journal of Hepatocellular Carcinoma. 2021;Volume 8:1459-1471   Crossref logo
Link1 Link2

Reply to: “Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B”
Journal of Hepatology. 2021;74(1):246-247   Crossref logo
Link1 Link2